Power Law company profile

Edgewise Therapeutics

Biotech & Life Sciences · Boulder, United States · Founded 2017 · IPO 2021 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$2.75B

Market cap · Apr/2026

Investors

15 investors on Edgewise Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 15 investors entered at this stage

Viking Global Investors

U.S. Venture Partners

New Leaf Venture Partners

Novo Seeds

Deerfield

Logos Capital

RA Capital Management

Cormorant Asset Management

Novo Holdings

OrbiMed

Janus Henderson Investors

Citadel

Wellington Management

Novo Ventures

Cure Duchenne

Global footprint

Where Edgewise Therapeutics has talent and traffic

Web traffic by country

7.6K monthly visits
across markets

🇺🇸 United States94.7%

🇮🇳 India5.3%

Top 2 markets shown

Patent intelligence

$15M patent portfolio · 15 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$15M

0.56% of market cap · 2.4× the top peer DICE Therapeutics ($6M)

15 active patent families

Where Edgewise Therapeutics innovates Pharmaceutical drugPyridazinePharmacologyDepressantQuinazolinone

Below peer median on Strategic

Quality vs same-sector peers

Edgewise Therapeutics on the five Patsnap quality dimensions

Edgewise Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Edgewise Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Edgewise Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Edgewise Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo